참고사항
수상내역
: 대한암학회 학술상 (사노피 신데라보) 2002 Biographical Record
: Marquis Who’s Who in the World 2008, Silver Anniversary (25th Edition)
: Marquis Who’s Who in the World 2009, 2010, 2011, 2012, 2013, 2014,2015, 2016, 2017, 2018, 2019
: Marquis Who’s Who in Medicine and Healthcare 2009-2010
: Marquis Who’s Who in 2017 Marquis Lifetime Award Winner 2017
: 2017 Albert Nelson Marquis Lifetime Achievement Award
: The 2018 Albert Nelson Marquis Lifetime Achievement Award Winners
: 2019 Lifetime Achievement Award
: International Biographical Center (IBC) Top 100 Health Professional 2012
: American Biographical Institute Man of the Year 2011, 2012
: Leading Health Professionals of the World 2013
: Leading Achiever of the World 201
: 보건복지부 장관상 2017
: 고려의대 임상강의상, 2017
: 고려대학교 석탑연구상 2018
학력
1986 .03 ~ 1992 .02 : 고려대학교 의과대학 의학과 학사
1996 .03 ~ 1998 .02 : 고려대학교 대학원 종양내과학 석사
1998 .03 ~ 2000 .08 : 고려대학교 대학원 종양내과학 박사
경력
1992 .03 ~ 1993 .02 : 고려대학교 의료원 수련의
1993 .03 ~ 1997 .02 : 고려대학교 의료원 내과 전공의
1997 .03 ~ 2001 .02 : 고려대학교 의료원 종양혈액내과 전임의
2001 .03 ~ 2002 .08 : 고려대학교 의료원 종양혈액내과 임상조교수
2002 .09 ~ 2005 .08 : 고려대학교 의과대학 종양내과 조교수
2005 .09 ~ 2011 .08 : 고려대학교 의과대학 종양내과 부교수
2007 .03 ~ 2009 .02 : University of Massachusetts, Amherst, Animal Science Research Associate (Dr. Joseph D Jerry)
2011 .09 ~ : 고려대학교 의과대학 종양내과 교수
학회
1997 .01 ~ : 항암화학요법연구회 정회원
2005 .01 ~ : 대한암예방학회 정회원
2006 .01 ~ : 한국임상암학회 이사
2010 .01 ~ : 대한암학회 학술위원
2010 .01 ~ : 대한암협회 총무위원
2007 .03 ~ : 대한내과학회 평생회원
2014 .03 ~ : 대한암학회 평생회원 및 이사
2012 .03 ~ : 한국임상암학회 상임이사
2015 .03 ~ : 한국유방암학회 회원 및 이사
~ : 대한종양내과학회 상임이사
논문
[SCI] (C-terminal HSP90 inhibitor L80 elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition,)
[SCI] (Investigation of B, C-ring truncated deguelin derivatives as heat shock protein 90(HSP90) inhibitor for use as anti-breast cancer agents)
[SCI] (Flubendazole overcomes trastuzumab resistance by targeting cancer stem-like properties and HER2 signaling in HER2-positive breast cancer.)
[SCI] (Current strategies of endocrine therapy in elderly patients with breast cancer.)
[SCI] (Flubendazole elicits anti-metastatic effects in triple-negative breast cancer via STAT3 inhibition)
[SCI] (Inhibition of ubiquitin-specific protease 34 (USP34) induces epithelial-mesenchymal transition and promotes stemness in mammary epithelial cells.)
[SCI] (Disulfiram Suppresses Cancer Stem-Like Properties and STAT3 Signaling in Triple-Negative Breast Cancer Cells)
[SCI] (Overexpression of angiotensin II type 1 receptor in breast cancer cells induces epithelial-mesenchymal transition and promotes tumor growth and angiogenesis)
[SCI] (Disulfiram targets cancer stem-like properties and the HER2/Akt signaling pathway in HER2-positive breast cancer)
[SCI] (Salinomycin possesses anti-tumor activity and inhibits breast cancer stem-like cells via an apoptosis-independent pathway)
[SCI] (Salinomycin promote anoikis and decrease the CD44+/CD24-stem-like population via inhibition of STAT3 activation in MDA-MB-231 cells)
[SCI] (YKL-40 expression could be as a poor prognostic marker in the breast cancer tissue)
[SCI] (Association of aldehyde dehydrogenase 1 expression and biologically aggressive features in breast cancer)
[SCI] (The relationship between preeclampsia, pregnancy-induced hypertension and maternal risk of breast cancer: a meta-analysis)
[SCI] (A randomized, multi-center, open-label, phase II study of once-per-cycle DA-3031, a biosimilar pegylated G-CSF, compared with daily filgrastim in patients receiving TAC chemotherapy for early-stage breast cancer)
[SCI] (The relationship between twin births and maternal risk of breast cancer: A meta-analysis)
[SCI] (The relationship between Helicobacter pylori infection and the effects of chemotherapy in patients with advanced or metastatic gastric cancer)
[SCI] (Bevacizumab for salvage treatment of metastatic breast cancer: A systemic review and meta-analysis of randomized controlled trials)
[SCI] (A phase II study of vinorelbine monotherapy in anthracycline and taxane pretreated metastatic breast cancer)
[SCI] (Association of a vascular endothelial growth factor (VEGF) gene 936 C/T polymorphism with breast cancer risk: a meta-analysis)
[SCI] (Bevacizumab for salvage treatment of metastatic breast cancer: A systemic review and meta-analysis of randomized controlled trials)
[SCI] (Association of a vascular endothelial growth factor (VEGF) gene 936 C/T polymorphism with breast cancer risk: a meta-analysis)
[SCI] (A phase II study of vinorelbine monotherapy in anthracycline and taxane pretreated metastatic breast cancer)
[SCI] (Association of a TGF-β1 509 C/T polymorphism with breast cancer risk: a meta-analysis)
[SCI] (High serum YKL-40 is a poor prognostic marker in patients with advanced non-small cell lung cancer)
[SCI] (Association of a progesterone receptor gene +331 G/A polymorphism with breast cancer risk: meta-analysis)
[SCI] (Sustained co-cultivation with human placenta-derived MSCs enhance ALK5/Smad3 signaling in human breast epithelial cells, leading to EMT and differentiation)
[SCI] (Docetaxel and epirubicin salvage regimen in anthracycline sensitive metastatic breast cancer patients relapsed after anthracycline-containing adjuvant therapy)
[국외논문] (Meta-analysis of pre-operative aromatase inhibitor versustamoxifen in postmenopausal woman with hormone receptor-positive breast cancer)
[국외논문] (Functional implication of Akt Activity and TGF-? signaling in Tamoxifen-resistanct Breast Cancer)
[국외논문] (Extrinsic NO donor partially reverse Arginine Deiminase (ADI) induced anti-proliferative activity through NFB and Bcl-XL)
[국외논문] (PPAR-γ ligand promote the growth of APC mutated colon cancer cell in vitro and in vivo)
[국외논문] (Amniotic membrane might be applied to cancer treatment)
[국외논문] (Epirubicin, Cisplatin, Oral UFT and Leucovorin Combination Chemotherapy in Advanced and Metastatic Esophageal Cancer)
(Phase II study of a Gemcitabine and Cisplatin combination regimen in taxane resistant metastatic breast cancer)
[국외논문] (uPAR expression under hypoxic conditions depends on iNOS modulated ERK phosphorylation in MDA-MB-231 breast carcinoma cell line)
[국외논문] (Autocrine VEGF/VEGF Receptor-2 Growth Pathway Represents a Cyclooxygenase-2-Independent Target for Cycooxygenase-2 Inhibitor NS-398 in Colon Cancer Cells)
동병원
동일과
LIST
폐암,두경부암,육종,내분비암
월요일오전
화요일오전
화요일오후
수요일오후
목요일오전
타병원
동일과
LIST
서울아산병원
림프종,다발골수종,만성림프구백혈병